|
Sign In to gain access to subscriptions and/or personal tools.
|
Oligomerisation of angiotensin receptors: novel aspects in disease and drug therapy
Liza Barki-Harrington
Department of Medicine, Duke University Medical Center, Durham, North Carolina USA, barki{at}duke.edu
The concept that 7 transmembrane receptors (7TMRs) exist and function as independent monomers has facilitated a therapeutic approach of selective targeting of receptors. However, oligomerisation of 7TMRs is now being recognised as an important biological phenomenon that adds a level of complexity to their signalling. In vitro, many 7TMR heterodimers display altered binding, signalling, and trafficking properties compared to their constituent monomeric units. This review discusses an emerging concept regarding the role of 7TMR heterodimerisation in vivo , and its significance to drug therapy. Studies of angiotensin receptor signalling indicate a pivotal role for heterodimerisation in the pathogenesis of human disorders. Furthermore, the occurrence of angiotensin receptor heterodimers has profound effect on the responsiveness to treatment with 7TMR blockers. Global assessment of the prevalence of different heterodimers during disease and their responsiveness to drug therapy is likely to optimise patient treatment and reduce side-effects associated with 7TMR blockers.
Key Words: heterodimerisation angiotensin receptor drugs
References
- Bockaert J., Pin JP Molecular tinkering of G protein-coupled receptors: an evolutionary success. Embo J 1999;18: 1723-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Terrillon S., Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep 2004;5:30-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- George SR, O'Dowd BF, Lee SP G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 2002;1:808-20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rocheville M., Lange DC, Kumar U. et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 2000;288:154-7.[Abstract/Free Full Text]
- White JH, Wise A., Main MJ et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998;396:679-82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jordan BA, Devi LA G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399:697-700.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- AbdAlla S., Lother H., Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000;407:94-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Terrillon S., Barberis C., Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.Proc Natl Acad Sci USA 2004;101:1548-53.[Abstract/Free Full Text]
- Bristow MR Why does the myocardium fail? Insights from basic science. Lancet 1998;352(suppl I): 8-14.[CrossRef]
- Bristow MR, Abraham WT Anti-adrenergic effects of angiotensin converting enzyme inhibitors. Eur Heart J 1995;16(suppl K):37-41.[Abstract]
- Schmaier AH The kallikrein-kinin and the reninangiotensin systems have a multilayered interaction. Am J Physiol Regul Integr Comp Physiol 2003;285:R1-13.[Abstract/Free Full Text]
- Monnot C., Bihoreau C., Conchon S. et al. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem 1996;271:1507-13.[Abstract/Free Full Text]
- AbdAlla S., Lother H.,Abdel-tawab AM et al.The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001;276:39721-6.[Abstract/Free Full Text]
- Barki-Harrington L., Luttrell LM, Rockman HA Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 2003;108:1611-18.[Abstract/Free Full Text]
- AbdAlla S., Lother H., el Massiery A. et al. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001;7:1003-09.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gomes I., Gupta A., Filipovska J. et al. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 2004;101:5135-9.[Abstract/Free Full Text]
- George SR, Fan T., Xie Z. et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000;275:26128-35.[Abstract/Free Full Text]
- Hillion J., Canals M.,Torvinen M. et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors.JBiol Chem 2002;277:18091-7.[Abstract/Free Full Text]
- Rapacciuolo A., Esposito G., Caron K. et al. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Card 2001;38:876-82.[Abstract/Free Full Text]
- Bristow MR Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997;80:26L-40L.[CrossRef][Medline]
[Order article via Infotrieve]
- Rockman HA, Koch WJ, Lefkowitz RJ Seven-transmembrane-spanning receptors and heart function. Nature 2002 415:206-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.[Abstract]
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-07.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Packer M., Coats AJ, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. NEnglJMed 2001;344: 1651-8.[Abstract/Free Full Text]
- Pfeffer MA, Swedberg K., Granger C. et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362:759-66.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Barki-Harrington L., Bookout AL, Wang G. et al. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J 2003;371:581-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hamm HE How activated receptors couple to G proteins. Proc Natl Acad Sci USA 2001;98:4819-21.[Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 2,
49-52 (2004)
DOI: 10.3317/jraas.2004.009

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|